Gemtesa 75 MG tablet 90S
Ended Awarded Last action
- Contract number
- SPE2DR26FBHE3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $37,499
Award facts
- Contract value 100% obligated
- $37,498.86 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on February 27, 2026, for GEMTESA 75 MG tablets (90-count) with a ceiling value of $37,498.86 under firm fixed-price terms.
Place of performance is Conshohocken, PA 19428. Ultimate completion date is March 2, 2026. The order carries no set-aside designation and was competitively awarded. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical distributor serving federal medical procurement.
Quick answers
Who was awarded contract SPE2DR26FBHE3?
SPE2DR26FBHE3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 27, 2026.
How much is contract SPE2DR26FBHE3 worth?
The government has obligated $37,499 on SPE2DR26FBHE3.
Is contract SPE2DR26FBHE3 an order under another contract?
Yes. SPE2DR26FBHE3 is a delivery order under SPE2DR25D2001, an indefinite delivery contract.
Was contract SPE2DR26FBHE3 competed?
The extent of competition for SPE2DR26FBHE3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award